Evidence map›Paper›PMID 22414604›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2012

Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.

Yong Zhao, Ying S Tan, Mark J Strynar, Gloria Perez, Sandra Z Haslam, Chengfeng Yang

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Endocrine Disruptors in Water and Their Effects on the Reproductive System.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Animal models of endocrine disruption.Best practice & research. Clinical endocrinology & metabolism · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yong ZhaoDepartment of Physiology, Michigan State University, East Lansing, MI 48824, United States; Breast Cancer and the Environment Research Center, Michigan State University, East Lansing, MI 48824, United States. Electronic address: yzhao@msu.edu.
Ying S TanDepartment of Physiology, Michigan State University, East Lansing, MI 48824, United States; Breast Cancer and the Environment Research Center, Michigan State University, East Lansing, MI 48824, United States. Electronic address: tanying@msu.edu.
Mark J StrynarHuman Exposure and Atmospheric Sciences Division, National Exposure Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: strynar.mark@epa.gov.
Gloria PerezDepartment of Physiology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: perezg@msu.edu.
Sandra Z HaslamDepartment of Physiology, Michigan State University, East Lansing, MI 48824, United States; Breast Cancer and the Environment Research Center, Michigan State University, East Lansing, MI 48824, United States. Electronic address: shaslam@msu.edu.
Chengfeng YangDepartment of Physiology, Michigan State University, East Lansing, MI 48824, United States; Breast Cancer and the Environment Research Center, Michigan State University, East Lansing, MI 48824, United States; Center for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: yangcf@msu.edu.
Michigan State University · USEnvironmental Protection Agency · US

Funding

Breast Cancer and the Environment Research CenterU01ES012800 · NIEHS · MICHIGAN STATE UNIVERSITY · PI HASLAM, SANDRA Z · 2003 to 2009
$5.6M
NCI NIH HHS U01 ES/CA 012800NIEHS NIH HHS U01 ES012800
6 · The paper itself

Abstract

Exposure to perfluorooctanoic acid (PFOA), a synthetic perfluorinated compound and an agonist of peroxisome proliferator-activated receptor α (PPARα), causes stunted mouse mammary gland development in various developmental stages. However, the underlying mechanisms remain poorly understood. We found that peripubertal PFOA exposure significantly inhibited mammary gland growth in both Balb/c and C57Bl/6 wild type mice, but not in C57Bl/6 PPARα knockout mice, and Balb/c mice were more sensitive to PFOA inhibition. PFOA caused (1) delayed or absence of vaginal opening and lack of estrous cycling during the experimental period; (2) decreases in ovarian steroid hormonal synthetic enzyme levels; and (3) reduced expression of estrogen- or progesterone-induced mammary growth factors. Supplementation with exogenous estrogen and/or progesterone reversed the PFOA inhibitory effect on mammary gland. These results indicate that PFOA effects on ovaries mediate its inhibition of mammary gland development in Balb/c and C57Bl/6 mice and that PPARα expression is a contributing factor.

Indexed as

AnimalsBlotting, WesternCaprylatesDose-Response Relationship, DrugEnvironmental PollutantsEstrogensFemaleFluorocarbonsKidneyMammary Glands, AnimalMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutOrganic Anion TransportersOvaryCaprylatesEnvironmental PollutantsEstrogensFluorocarbonsOrganic Anion Transportersperfluorooctanoic acidPPAR alphaProgesterone

Identifiers

PMID22414604
PMCPMC3362693
OpenAlexW2046127223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.